1-4 of 4
Kohmei Kubo, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Kazunori Murai, MD, PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD, PhD, Takuto Miyagishima, MD, PhD, Motohiro Shindo, MD PhD, Kentaro Wakasa, MD, PhD, Mitsue Inomata, MD, PhD, Takahiro Nagashima, MD, PhD, Takeshi Kondo, MD PhD, Nozomu Fujimoto, MD, PhD, Satoshi Yamamoto, PhD MD, Masakatsu Yonezumi, MD, PhD, Tatsuo Oyake, MD, PhD, Shugo Kowata, MD PhD, Yasuhiko Tsukushi, MD PhD, Takahiro Mine, MD, Kuniaki Meguro, MD PhD, Kazuhiko Ikeda, MD PhD, Reiko Watanabe, MD PhD, Souichi Saito, MD, PhD, Shinji Sato, MD, PhD, Takaaki Chou, MD, PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3102.
https://doi.org/10.1182/blood.V128.22.3102.3102
Published: 2016
Journal Articles

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Kazunori Murai, MD PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD PhD, Tomoaki Akagi, Kazuei Ogawa, MD PhD, Inomata Mitsue, Kuniaki Meguro, Reiko Watanabe, MD PhD, Takuto Miyagishima, MD, PhD, Kentaro Wakasa, Motohiro Shindo, MD PhD, Yasuhiko Tsukushi, MD PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 4052.
https://doi.org/10.1182/blood.V126.23.4052.4052
Published: 2015
Journal Articles

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Mitsune Tanimoto, MD PhD, Koichi Miyamura, Toshihiro Miyamoto, MD PhD, Kazuhito Yamamoto, Masafumi Taniwaki, Shinya Kimura, MD, Kazuma Ohyashiki, Tatsuya Kawaguchi, MD PhD, Itaru Matsumura, Tomoko Hata, MD PhD, Hisashi Tsurumi, MD PhD, Shigeki Saito, MD PhD, Masayuki Hino, MD PhD, Seiji Tadokoro, Kuniaki Meguro, MD PhD, Hideo Hyodo, MD, Masahide Yamamoto, MD PhD, Kohmei Kubo, MD PhD, Junichi Tsukada, MD, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada
Journal: Blood
Blood (2014) 124 (21): 1815.
https://doi.org/10.1182/blood.V124.21.1815.1815
Published: 2014
Journal Articles

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Koichi Miyamura, MD, PhD, Toshihiro Miyamoto, MD, Mineo Kurokawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Masafumi Taniwaki, MD, PhD, Shinya Kimura, MD, PhD, Kazuma Ohyashiki, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Itaru Matsumura, MD, PhD, Tomoko Hata, MD, PhD, Hisashi Tsurumi, MD, PhD, Shigeki Saito, MD, PhD, Masayuki Hino, MD, PhD, Seiji Tadokoro, Kuniaki Meguro, M.D., Ph.D., Hideo Hyodo, MD, Masahide Yamamoto, MD, Kohmei Kubo, MD, Junichi Tsukada, Midori Kondo, Taro Amagasaki, PhD, Eiji Kawahara, PhD, Masamitsu Yanada
Journal: Blood
Blood (2013) 122 (21): 2729.
https://doi.org/10.1182/blood.V122.21.2729.2729
Published: 2013